The original success of Sildenafil undeniably revolutionized the medication landscape, but betting in companies strongly reliant on generic versions presents a challenging picture. While early returns were substantial, the expiration of patents and the appearance of discounted alternatives have eroded the customer base. Consequently, a thorough ass